An estimated 30-70% of available medications in low-income countries and conflict states are of low quality or copyright. Reasons for this vary but most are rooted in regulatory agencies being poorly equipped to oversee quality of pharmaceutical stocks. This paper presents the development and validation of a method for point-of-care drug stock quality testing in these environs. https://www.roneverhart.com/Monarch-Butterfly-Life-Cycle-Stuffed-Animal-Puppet/